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Activation of muscarinic cholinergic receptors was studied by measuring agonist-stimulated inositoi lipid 
turnover and changes in [Ca2+]i in dissociated salt gland secretory cells. Carbachol stimulation of 
quin2-1oaded cells results in a sustained 4-fold increase in [CaZ+]i , while incorporation of [32pIP i into 
phosphatidylinositol (PI) and phosphatidate are similarly increased. [3H]Inositol phosphates, measured in 
the presence of Li +, increased 13-fold. The stimulated increment in [Ca z÷ ]i required extracellular Ca 2÷, 
whereas [3Hlinositol phosphate accumulation was independent of external Ca z +. Dose-response curves for 
carbachoMnduced increments in [Ca2+]i, P1 labeling, and labeled inositol phosphate release are similar, with 
ECs0 values of 6, 4.5 and 8 /~M, respectively. Dissociation constants for atropine vs. the quin2 and 
phospholipid responses are 0.59 + 0.3 nM and 0.48 + 0.28 nM, respectively. These cells thus provide a 
model system for the study of non-exocytotic secretion as a consequence of stimulated inositol lipid 
turnover. 
Introduction 
Studies on stimulus-response coupling in exo- 
crine glands provide information concerning the 
mechanisms by which intracellular mediators link 
neurohormonal receptor activation to secretory 
function. In a wide variety of exocrine tissues, 
secretion of proteins a n d / o r  electrolytes and water 
* Present addrcss: T Cell Sciences Inc., 840 Memorial Drive, 
Cambridge, MA 02139. U.S.A. 
Abbreviations: PI, phosphatidylinositol: Pi, inorganic phos- 
phate. 
Correspondence: Dr. B.W. Agranoff, Neurosciencc Laboratory 
Building, University of Michigan, Ann Arbor, MI 48104-1687, 
U.S.A. 
depends on the elevation of the intracellular 
calcium concentration ([Ca2+]i [1]). This Ca 2+ 
response can be triggered by occupation of a 
variety of plasma membrane receptors, including 
the widely distributed muscarinic acetylcholine re- 
ceptor (mAChR) [2,3]. Labeling studies have 
shown that activation of mAChRs can also result 
in stimulated turnover of membrane phosphoino- 
sitides [1,4-6]. 
Avian salt glands provide a useful model tissue 
for studying these events. In response to a dietary 
salt load or to direct cholinergic stimulation, these 
glands secrete a hypertonic fluid which is rich in 
NaCI and devoid of macromolecules such as pro- 
teins [7]. Study of stimulus-response mechanisms 
in this tissue, therefore, are not complicated by 
exocytotic function superimposed on fluid secre- 
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tion, features that are commonly shared by many 
exocrine glands. The mAChRs have been char- 
acterized in salt glands by ligand binding studies 
with homogenates and intact dissociated cells [8,9], 
and have been localized autoradiographically along 
basolateral membranes of the secretory epithelium 
[9]. In vitro studies with salt glands have demon- 
strated that stimulation of mAChRs elicits a 
variety of physiological events associated with ion 
secretion, including increases in ouabain-sensitive 
oxygen consumption [10-12], stimulation of Na + 
efflux [13], potentiation of Na + pump activity 
[14], elevation of cGMP levels [12] and induction 
of transmural short-circuit currents [15]. More 
proximal responses to mAChR activation have not 
been studied in detail, although both Ca 2+ and 
phospholipid turnover have been implicated indi- 
rectly on the basis of Ca 2+ dependence of stimu- 
lated ouabain-sensitive respiration [12] and in- 
creased turnover of phosphatidylinositol (PI) and 
phosphatidate following exposure of salt gland 
slices to cholinomimetic agents [16]. Additionally, 
little is known concerning the possibility that a 
muscarinic receptor subtype mediates these vari- 
ous responses in salt gland. 
In the present study, we have characterized the 
functional activation of mAChR by cholino- 
mimetic agents in dissociated salt gland cells. We 
show that unlike the response in exocrine glands 
such as the pancreas [17-19], agonist-induced 
Ca 2+ mobilization in salt gland cells results in a 
sustained elevation of [Ca2+]i, and that the rise in 
[Ca2+]i is dependent on extracellular Ca 2+. 
Stimulated breakdown of phosphoinositides in 
contrast is independent of external Ca 2+. A pre- 
liminary report of some of these results has been 
presented in abstract form [20]. 
Materials and Methods 
Animals. Pekin ducklings were purchased from 
Ridgeway Hatcheries (La Rue, OH) and main- 
tained on commercial poultry feed. Adaptation of 
the salt glands was induced by adding 1% NaC1 to 
the drinking water for at least 1-2 weeks prior to 
experiments [11,21]. 
Materials. Carbachol, acetylcholine, methacho- 
line, muscarine, bethanechol, arecoline, pilocar- 
pine, atropine, type I collagenase, type I-S 
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hyaluronidase, chymotrypsin, Hepes, ouabain, 
EDTA, EGTA and type I-S trypsin inhibitor were 
all purchased from Sigma Chemical Co. (St. Louis, 
MO). Eagle's minimal essential medium with 
Earle's salts was obtained in powdered form from 
Gibco (Grand Island, NY). Dowex 1-X8 (formate 
form, 100-200 mesh) was from Bio-Rad (Rich- 
mond, CA). Pirenzepine and McN-A-343 were 
generous gifts of Dr. Karl Thomae, GmbH 
(F.R.G.) and Dr. Stephen K. Fisher, respectively. 
Quin2 acetoxymethyl ester was purchased from 
Calbiochem (La Jolla, CA). [32p]p i (carrier-free) 
was a product of Amersham (Arlington Heights, 
IL), and myo[2-3H]inositol (14 Ci /mmol)  was 
from American Radiolabeled Chemicals, Inc. (St. 
Louis, MO). All other chemicals used were of 
reagent grade. 
Preparation of dispersed salt gland cells. A disso- 
ciated suspension of duck salt gland cells was 
obtained as previously described [11]. Physiologi- 
cal and morphological characteristics of this cell 
preparation are described in detail elsewhere 
[9,11,14]. Cells were resuspended after isolation in 
Hepes-buffered Krebs Ringer (buffer 1) solution 
consisting of (mM): NaC1, 118.7; KC1, 4.8; CaCI2, 
1.3; NaHCO3, 4.8; MgSO4, 1.2; KH2PO4, 1.2; 
glucose, 6.0; and Na-Hepes, 10.0. The pH of the 
medium was adjusted to 7.4 with 1.0 M HC1. 
Measuremeni of 3Zp phospholipid labeling. Fol- 
lowing isolation, the cells were gently centrifuged 
and resuspended in a phosphate-free physiological 
salt solution (buffer 2) consisting of (mM): NaC1, 
142; KC1, 5.6; CaCI2, 2.2; NaHCO 3, 3.6; MgC12, 
1.0; glucose, 5.6; and Hepes, 30 (adjusted to pH 
7.4). Aliquots of dissociated salt gland cells (3-4- 
10 6 cells per 0.5 ml final vol.) were transferred in 
buffer 2 to tubes and incubated with [32p]p i (ap- 
prox. 15/~Ci per tube) in the presence or absence 
of various muscarinic agonists. Incubations were 
terminated after 30 rain by the addition of 1.5 ml 
of chloroform/methanol (1 : 2). Tubes were stored 
on ice for 15-60 min, after which 0.5 ml of 2.4 M 
HC1 and 1.0 ml of chloroform were added [22]. 
The tubes were vigorously vortexed (30 s) and the 
phases were separated by centrifugation. The chlo- 
roform layer was transferred to a separate tube 
and the aqueous layer and protein interface was 
re-extracted with an additional 1.0 ml of chloro- 
form. The chloroform layers were combined and 
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extracted once with 2.25 ml of me thano l /wa te r /  
2.4 M HC1 (1 : 1 : 0.25, v/v).  After vortexing and 
centrifugation, the upper aqueous layer was re- 
moved by aspiration. A portion (200 /tl) of the 
lower layer was removed and scintillation counted 
in order to establish recovery, while the remainder 
of the organic phase was taken to dryness under 
nitrogen. The phospholipids were reconstituted in 
100 ~1 of chloroform/methanol  (2: 1, v /v )  and 
the entire contents spotted on TLC plates (Merck, 
Darmstadt, Silica gel 60, 20 × 20 × 0.25 cm) which 
had previously been run in a solution containing 
1.2 g of potassium oxalate in 40 ml of methanol 
and 60 ml of water, then activated immediately 
before use by heating for 10-20 min at l l 0 °C .  
Lipids were separated, as previously described [22], 
by TLC in a solvent system containing chloro- 
form,/  a c e t o n e / m e t h a n o l / a c e t i c  a c i d / w a t e r  
(40 : 15 : 13 : 12 : 7). Lipid bands were visualized by 
au torad iography,  scraped and scintillation 
counted. 
[3H]Inositol experiments. Myo-[2-3H]inositol 
was passed over a Dowex-1 (formate) column to 
remove possible acidic contaminants before use. 
Release of inositol phosphates from cells pre- 
labeled with [3H]inositol in the presence of Li + 
was determined by a batch-absorption procedure 
on Dowex-1 (formate), essentially as described by 
Fisher et al. [23]. In brief, freshly isolated cells 
were centrifuged and resuspended (1 -107 /ml )  in 
buffer 2 containing 5-20 /~Ci/ml of myo-[2- 
3H]inositol (14 C i /mmol )  and incubated at 37°C 
for 60 min. Following the preincubation period, 
450 ktl of the cell suspension was added to 50/~1 of 
agonist and the reaction was allowed to proceed 
for an additional 30 min in the presence of Li + 
(10 raM). The cells were gassed with 95% 02 /5% 
CO 2 at 15-30 min intervals during the incuba- 
tions. The reaction was stopped by the addition of 
1.5 ml of chloroform/methanol  (1 : 2 v /v)  and the 
tubes were stored on ice for 15-60 rain. After 
addition of 1 ml of chloroform and 0.5 ml of 
water, the tubes were vortexed vigorously and the 
phases were separated by centrifugation, A por- 
tion (1.4 ml) of the upper (aqueous) phase was 
removed and heated at 50°C for 15 min to remove 
traces of chloroform, brought to 3.0 ml with water, 
and 0.5 ml of a 50% (w/v)  slurry of Dowex-1 
(formate) was added. Following vigorous vortex- 
ing and centrifugation, the supernatant layer was 
aspirated and the resin was washed four times 
with 2.5 ml of 5 mM myo-inositol. Labeled in- 
ositol phosphates were eluted from the resin with 
1 ml of 1 M ammonium formate/0.1 M formic 
acid of which a 0.8 ml portion was counted. For 
separation of individual [3H]inositol metabolites, 
the aqueous layer of cell extracts was applied to 
Dowex-1 (formate form) ion-exchange columns 
and eluted as described by Berridge et al. [26]. 
[Ca2+], measurement. Dissociated cells were 
loaded with quin2 acetoxymethyl ester (quin2/  
AM) using a procedure similar to that described 
by Tsien et al. [24]. Cells at a concentration of 
8-12 • 1 0  6 per ml were incubated at 37°C in buffer 
1 at pH 7.4 with 50/~M quin2/AM.  After 30 min 
the cells were diluted to approx. 3. 106/ml and 
allowed to incubate 15 min longer, after which 
they were centrifuged and resuspended in fresh 
medium (10.106 cells/ml) and maintained at 
room temperature up to 2 h. A 1 ml vol. contain- 
ing 10 .10  6 cells was placed in a cuvette and 
constantly stirred at 37°C throughout the fluores- 
cence recording. Excitation and emission wave- 
lengths were 339 _+ 4 and 490_+ 10 nm, respec- 
tively. Quin2 fluorescence recordings were ob- 
tained on an Aminco-Bowman Spectrophotofluo- 
rometer interfaced with both a strip-chart recorder 
and an LED readout, from which numerical val- 
ues were recorded at regular intervals and were 
used to quantitate [Ca2+]i using the equations 
described by Tsien et al. [24,25]. 
Results 
Changes in [Ca: +], 
Quin2-1oaded cells challenged with carbachol 
displayed a dose-dependent, sustained increase in 
[Ca2+]i which was antagonized by atropine in a 
similar, cumulative manner. The calculated resting 
cytosolic [ C a 2 + ] i  w a s  197 _+ 20 nM ( X +  S.E., n = 
16) and maximally effective carbachol concentra- 
tions (10 -3 M) increased the [Ca2+]i to 759 +_ 84 
nM. The agonist-induced rise in [Ca2+]i was sta- 
ble for at least 10 min, the longest time interval 
measured in these experiments. 
Loading cells with quin2 allows quantitation ol 
[Ca2+]i, but also may effect changes in Ca 2+ 
homeostasis due to the buffering capacity of the 
indicator. To examine such effects, cells were 
loaded with 10, 20 and 50/~M of quin2/AM, and 
carbachol-stimulated changes in [Ca2+]i were 
measured. The major effect of varying the in- 
tracellular quin2 concentration was on the kinetics 
of the carbachol-stimulated alteration in [Ca 2 +]i. 
Specifically, the carbachol-induced (10-3 M) max- 
imal change in [Ca2+] i was reached in 32.5 + 2.5, 
67.8 + 5.7, and 192.5 _+ 17.5 s (n = 2-4) in cells 
loaded with 10, 20 and 50/~M quin2/AM, respec- 
tively. Loading cells with these various quirt2 con- 
centrations, however, did not significantly alter 
the calculated basal or stimulated [Ca2+] i, nor did 
it affect the carbachol concentration quin2 fluo- 
rescence response relationship. 
3zP-lipid labefing 
Muscarinic acetylcholine receptor (mAChR) 
activation stimulated the de novo incorporation of 
[32P]P i into PI, with maximally effective carbachol 
concentrations (10 4 - 1 0 - 3  M )  eliciting a 3.4 + 
0.55-fold increase over basal 32p labeling (n = 11). 
Carbachol caused similar increases in [32pIP i in- 
corporation into phosphatidate, while no signifi- 
cant effects on phosphatidylinositol 4-phosphate 
(PIP) or phosphatidylinositol 4,5-bisphosphate 
(PIP 2) were observed. 
[-W] Inositol phosphates 
A convenient and sensitive assay for agonist- 
induced activation of the inositide cycle is by 
measurement of the release and accumulation of 
[3H]inositol phosphates in the presence of Li +, 
which prevents degradation of inositol 1-phos- 
phate (IP1) generated from phospholipid turnover 
[26,27]. In dissociated avian salt gland cells, 
carbachol stimulated labeled inositol phosphate 
release 13.4 + 3.5-fold (n = 3) over basal values 
(see also legend to Fig. 1). The carbachol con- 
centration-response relationships for increases in 
[Ca2+]i , [32p]PI labeling and [3H]inositol phos- 
phate release fit a similar dose-response curve 
(Fig. 1). ECh0 (concentration which stimulates 50% 
of maximum) values were 4.5, 6, and 8 /LM for 
[32p]PI, [Ca2+]i and [3H]inositol phosphate re- 
lease, respectively (Fig. 1). The similarity of dose- 
responses for 32p labeling of PI and for release of 
labeled inositol phosphates reflects the probability 
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Fig. 1. Dose-response relationships for carbacho]-induced 
changes in quin2 fluorescence, [32p]PI and [3H]inositol phos- 
phate release. Data are plotted as a percentage of maximal for 
each response. The resting cytosolic [Ca 2+ ]i was 197_+ 20 nM, 
and a maximally effective carbachol concentration (10- 3 M) 
increased the [Ca2*]i to 759_+84 nmol ( n = 9 ) .  Basal 32P i 
incorporation into PI was 3640+660 dpm, while stimulated 
values for [32P]PI were 13500_+2360 dpm ( n = 6 ) .  Basal 
[3H]inositol phosphate release was 890_+10 dpm and 
carbachol-stimulated release averaged 9910 + 2580 dpm (n = 3). 
The absence of an error bar indicates that the S.E. was within 
the margins of the symbol. The EC50 values for quin2 (e, 
n = 5), [32p]PI (A, n = 6) and [3H]IP (8, n = 3) were 6.0_+ 1.2 
/~M, 4.5_+0.7 ttM and 8.0_+0.2 /~M, respectively. 
activation of the inositide cycle in salt gland cells. 
Analysis of individual [3H]inositoi phosphates 
was performed in cells labeled with [3H]inositol 
(20 ~Ci /ml ,  90 rain), then stimulated with 
carbachol (10 3 M) for intervals ranging from 10 
s to 30 min in the presence of 10 mM Li +. The 
reactions were terminated by adding either 1.5 ml 
chloroform/methanol (1 : 2 v/v),  or 550/~1 of 1.0 
M trichloroacetic acid (followed by diethyl ether 
extraction of the aqueous supernatant), and 
[3H]inositol metabolites were separated by ion-ex- 
change chromatography (Dowex-1, formate form) 
as previously described [26]. The major [3H]in- 
ositol metabolite detected at both short (30 s) and 
long (30 min) incubation times was IP 1, which 
accounted for the largest part of the receptor 
response (89% of the total radioactivity). Labeled 
inositol bisphosphate (IP2) increased approx. 
2-4-fold upon mAChR stimulation and repre- 
sented about 2-9% of the labeled metabolites, 
while labeled inositol trisphosphate (IP3) was 
increased about 45-60% over basal levels and 
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consti tuted less than 4% of the total [3H]inositol 
phosphates. 
Ca-' + dependeno' of responses 
To examine whether the carbachol- induced 
elevation in [Ca2+]t is dependent  on extracellular 
Ca 2~ , quin2-1oaded (50/~M q u i n 2 / A M )  cells were 
resuspended in CaZ+-free buffer 1, or in Ca2+-free 
buffer 1 conta in ing  0.1 m M  EGTA.  Under  these 
conditions,  carbachol failed to produce a change 
in [Ca2+]i . In order to avoid possible deleterious 
effects of relatively prolonged incubat ion  (e.g., 30 
rain) of cells in Ca2+-free media, quin2 loaded 
cells in normal  Ca2+-containing buffer 1 were 
treated with E G T A  30-45 s before the addi t ion of 
agonist. Under  these conditions,  carbachol still 
failed to produce a detectable increase in [Ca2+]i 
(Fig. 2). Readdi t ion of 1.5 mM [Ca 2+] to the 
incuba t ion  med ium restored [Ca2+]i to the 
elevated level seen in st imulated control cells (Fig. 
2). Subsequent  addi t ion of atropine partially 
blocked this response, restoring [Ca2+]i t o  the 
near normal resting levels generally measured in 
the absence of EGTA.  In control experiments, 
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Fig. 2. Carbachol-stimulated changes in [Ca 2+ ]i in the ab- 
sence of extracellular Ca 2 +. Quin2-1oaded salt gland cells were 
assayed to determine changes in [Ca 2+ ]i. Immediately prior to 
addition of carbachol. 1.5 mm EGTA was added to chelate 
medium Ca 2 '. Under these conditions, carbachol failed to 
produce changes in [Ca 2+ ]i until the readdition of normal 
[Ca 2 ' ]. This experiment was typical of four experiments. The 
same results were obtained in experiments in which the cells 
were suspended in calcium-free Krebs-Ringer-Hepes buffer 
without EGTA. 
TABLE I 
Ca 2. DEPENDENCY OF [3H]INOSITOL PHOSPHATE 
RELEASE FROM CARBACHOL-STIMULATED SALT 
OLAND CELLS 
Values represent X + S.E. dpm for triplicate determinations 
normalized for total cellular radioactivity between groups, and 
are representative of results obtained in three separate experi- 
ments. Cells were prelabeled with [3H]inositol in the absence 
of Li' for 60 rain, after which the incubation volume was 
divided into three equal portions. Cells were pelleted by 
centrifugation and resuspended in the appropriate buffer. This 
procedure was repeated twice, at which time a 10/ll portion of 
the final suspension was removed and scintillation counted. 
The labeled cells were then distributed to tubes containing 
buffer or carbachol and Li ', and further incubated for 30 min. 
[ 3 H]Inositol phosphate 
Basa l  Carbachol (1.0 raM) 
Control 5480_+200 47200_+1500 
Ca 2+ 2080_+320 42900_+2350 
Ca 2+ 4-1 mM EGTA 1540+120 30200+1 160 
carbachol and atropine were added prior to the 
readdit ion of Ca z+, whereupon [Ca2+]~ returned 
to normal  resting levels. 
The Ca2+-dependency of mAChR-s t imula ted  
labeled inositol phosphate release was examined 
to further elucidate the interrelat ionship between 
various salt gland responses. In contrast  to the 
absolute dependency for extracellular Ca 2. on 
receptor-induced elevations in [Ca2+]i (Fig. 2), the 
absence of external Ca 2+ did not alter [3H]in- 
ositol phosphate release (Table I). Moreover, a 
significant increase in labeled inositol phosphates 
was still evident in cells subjected to prolonged 
exposure to 1 mM EGTA, although the magni tude  
of this response was depressed somewhat as com- 
pared with control cells (Table l). 
Muscarinic acetylcholine receptor (mA ChR) subtype 
characterization 
To further characterize the m A C h R  responses 
in avian salt g land cells, pharmaco log ica l  
antagonists  and a series of muscarinic agonists 
were examined. Atropine  and pirenzepine antago- 
nized the [ 32 P]PI and Ca 2 ~-quin2 responses elicited 
by carbachol in a concent ra t ion-dependent  manner  
(Figs. 3 and 4, respectively). The dissociation con- 
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Fig. 3. Atropine inhibition of carbachol-stimulated changes in 
Ca 2 ~ and [32pIPI in dissociated avian salt gland cells. Each 
point is the mean ( _+ S.E.) plotted as percent inhibition and is 
based on 3-5 separate experiments. Quin2 (e): IC5o = 10 7 M, 
[carb] =10 3 M; Ki = 0.59+0.30 nM. [32pIPI (A): ICho 10 s 
M, [carb] = 10 4 M; K i = 0.48 + 0.28 nM. 
calculated using ICh0 values derived from dose-in- 
h ib i t ion  curves (Figs. 3 and 4) by the method of 
Cheng and  Prusoff [28]. The K i values for atro- 
pine vs. the quin2 and [32P]PI responses were 
0.59 _+ 0.30 n M  (n = 3) and  0.48 + 0.28 n M  (n = 
6), respectively (Fig. 3). Pirenzepine antagonism of 
quin2 and [32p]PI responses yielded K i values of 
227_+ 67 n M  (n = 5) and 90.2_+ 2.1 nM (n = 4), 
respectively (Fig. 4). 
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Fig. 4. Pirenzepine inhibition of carbachol-induced changes in 
quin2 fluorescence and [32p]PI in dissociated avian salt gland 
cells. Each point represents the mean (+_ S.E.) percent inhibi- 
tion based on 3-5 replicates of the experiment. Quin2 (o): 
iC5o=4.5.10 6 M, [carb]=10 -4 M; Ki=227+67nM. 




AGONIST EFFICACY FOR STIMULATION OF RE- 
SPONSES IN SALT GLAND CELLS 
Data are expressed (X + S.E., n = 3) as percent of carbachol 
stimulation. In three experiments conducted with the agonist 
as described in Materials and Methods, basal and carbachol- 
stimulated 32p incorporations into PI were, respectively, 9210 
and 42400 dpm, 7990 and 24000 dpm; 1330 and 5430 dpm. 
Basal free [CaZ+]i as measured by quin2 fluorescence was 
197+20 nM and carbachol increased [Ca 2+ ]i to 759_+ 84 nM 
(n = 9). 
Agonist PI labeling [Ca 2 + ]i 
(10 3 M) (stimulation, %) (stimulation, %) 
Carb achol 100 100 
Acetylcholine 97 + 2 128 +_ 20 
Muscarine 108 _+ 4 97 +_ 12 
Methacholine 92 + 6 71 _+ 8 
Arecoline 69 + 7 44_+ 6 
Bethanechol 61 + 5 43 + 6 
Pilocarpine 12 + 9 0 
McM-A-343 0 0 
maximal ly  effective concentra t ion  (10 -3 M) for 
their abili ty to enhance PI labeling and quin2 
responses in dissociated salt gland cells (Table II). 
Addi t ion  of carbachol,  acetylcholine, muscarine or 
methachol ine  resulted in larger responses than did 
arecoline or bethanechol.  Pilocarpine and McN-A-  
343 were without  effect in either system. With  the 
exception of acetylcholine and muscarine,  all other 
agonists tested were slightly more effective in 
s t imulat ing the [32p]PI labeling than in augment-  
ing [Ca 2 + ]i-  
D i s c u s s i o n  
Receptor act ivation of tissues by cholinomi-  
metic agents is thought to be t ransduced into 
intracel lular  responses via breakdown of inositol 
lipids and mobil izat ion of Ca 2+ [1-5]. In  tissue 
slices from salt glands, cholinergic s t imulat ion of 
ouabain-sensi t ive respirat ion is dependent  on the 
presence of Ca 2+ in the med ium [12]. In  addit ion,  
muscarinic  receptor activation in conf luent  cul- 
tures of salt gland cells [15] can be mimicked with 
the Ca 2+ ionophore  A23187 which also elicits a 
short-circuit  current,  consistent with electrogenic 
chloride secretion, that is blocked by ouaba in  and 
furosemide [29]. 
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Early studies by Hokin and Hokin [16] indi- 
cated that cholinergic stimulation of salt gland 
tissue slices increased the turnover of phosphati- 
date and PI. Using 32p-prelabeled dissociated cells, 
we showed that carbachol elicits a rapid atropine- 
sensitive loss of radiolabel from PIP and PIP 2 and 
an increase in labeling of phosphatidate within 
1-2  min [30]. Stimulated labeling of PI was detec- 
table only after 5 rain. These data suggest that, as 
in other stimulated tissues [4-6], breakdown of 
polyphosphoinositides precedes stimulated label- 
ing of phosphatidate and PI, the latter being 
regarded as the restorative phase of an inositol 
lipid labeling cycle which eventually resynthesizes 
PIP 2. 
The present results extend these observations 
by directly relating changes in [Ca2*]i and stimu- 
lated turnover of phosphoinositides to muscarinic 
receptor activation of dissociated cells. The corre- 
spondence between ECs0 values for carbachol-in- 
duced increments in [Ca2+]i, [32p]PI labeling, and 
release of [3H]inositol phosphates (Fig. 1), and 
between K i values for inhibition of these responses 
by atropine and pirenzepine (Figs. 3 and 4, respec- 
tively), provide compelling evidence that PI 
turnover and Ca 2+ mobilization are mediated by 
the same receptor. 
Studies with a number of tissues indicate that 
receptor-stimulated breakdown of phosphatidyl- 
inositol 4,5-bisphosphate (PIP2) leads to the for- 
mation of 1,4,5-IP 3 and diacylglycerol (Refs. 
4,5,31). IP 3 has been shown to induce the release 
of intracellular bound Ca 2+ from permeabilized 
cells [32,33] and, more specifically, from endo- 
plasmic reticulum preparations obtained by sub- 
cellular fractionation of rat pancreas [33,34]. In 
salt glands, the demonstration of stimulated 
breakdown of polyphosphatidylinositides [30], 
combined with the generation of inositol phos- 
phates, and the concomitant rise in [Ca2+]i fol- 
lowing cholinergic stimulation, are consistent with 
the notion that these responses are an early conse- 
quence of receptor-ligand interaction. However, 
some important differences exist between the 
responses seen in salt glands and those that have 
been described in other tissues, such as the pan- 
creas. 
The data presented in Fig. 2 indicate that the 
atropine-sensitive rise in [Ca2+]i following carba- 
chol stimulation reaches a stable plateau and that 
the initial elevation is dependent on the presence 
of extracellular Ca 2+. This mode of Ca 2+ mobili- 
zation by muscarinic agonists differs from that 
seen in pancreatic acinar cells where the initial rise 
in [Ca 2+]i subsequently falls to a lower sustained 
level and is elicited even in the absence of ex- 
tracellular Ca 2+ with EGTA present [18,19]. A 
similar pattern to that of the pancreas, and other 
acinar cell types [35] has been described for 
cholinergic stimulation of a neurosecretory cell 
line (PC12 cells [36]). It is not likely that method- 
ology accounts for differences between the ob- 
served pancreatic and salt gland Ca2+-quin2 re- 
sponses, since we also have been able to show that 
guinea pig pancreatic acinar cells, prepared in the 
same manner as salt gland cells, produce the ex- 
pected Ca 2+ pattern for pancreatic tissue (data 
not presented). 
In pancreatic acinar cells [33,34], as well as 
other cell types [5], Ca z+ has been shown to be 
released from non-mitochondrial stores by Ip~, 
thereby providing a cellular mechanism for the 
initial Ca2+-independent phase of receptor stimu- 
lation. The present data suggest, however, that the 
early phase of rapid rise in [Ca2+]i in salt gland 
cells, as well as the sustained phase, is strictly 
dependent on extracellular Ca 2+ (Fig. 2). In this 
regard, recent studies with cholinergic stimulation 
of parietal cells [37,38] show a similar quin2 fluo- 
rescence pattern to that presented here for salt 
gland cells, including a prolonged stable plateau 
without subsequent decay, and significantly, strict 
reliance of the response on extracellular Ca 2+. In 
these studies, intracellular Ca 2 ~ mobilization was 
attributed to enhanced plasma membrane permea- 
bility to Ca 2+ without release of Ca 2+ from in- 
tracellular sources. It should be noted in this 
context that in contrast to pancreatic acinar cells~ 
salt gland cells lack the abundant endoplasmic 
reticulum [21] which serves as the source for Ca ~ + 
release in some tissues [33,34]. 
Although a variety of mechanisms have been 
proposed which could relate phosphoinositide 
metabolism to increased plasma membrane per- 
meability to C a  2~ , none have, as yet, been directly 
demonstrated [4,5]. In the present study, some 
data are presented that raise the question as to 
whether IP 3 release and mobilization of Ca 2+ are 
always causally related or whether in some 
instances they can be parallel consequences of 
mAChR activation. In salt gland cells, stimulated 
alterations in [Ca2+]i were dependent on the pres- 
ence of extracellular Ca 2+ (Fig. 2), whereas labeled 
inositol phosphate accumulation was essentially 
independent of Ca 2+ (Table I). Accordingly, these 
studies confirm that receptor-activated inositide 
breakdown is a proximal event and, as has been 
previously demonstrated [39], is not CaZ+-regu- 
lated. However, there is as yet no evidence that IP 3 
is produced in significant quantities or that Ca 2+ 
is released from intracellular stores in the avian 
salt gland as a consequence of receptor activation. 
It is possible that efficacious amounts of IP 3 are 
released and degraded too rapidly to measure by 
current assay procedures. An alternative explana- 
tion may be that the labeled IPt is formed prim- 
arily by breakdown of PI, largely bypassing IP 3 
formation. For the present, the data in both the 
avian salt gland and parietal cells lead us to 
conclude that extracellular Ca 2+ entry is effected 
by an as yet unidentified mechanism as a direct 
result of receptor activation. One possible mecha- 
nism for this Ca 2+ entry may be via a GTP-bind- 
ing protein acting on an ion channel as has re- 
cently been demonstrated in dorsal root ganglion 
neurons [40]. 
The muscarinic receptor in salt glands may be 
classified on the basis of functional criteria (e.g., 
Ca 2+ mobilization, stimulated PI turnover) as be- 
longing to the M 1 subclass. Pharmacological sub- 
classification of muscarinic receptors [41] has been 
based primarily on the actions of the selective 
agonist McN-A343 and the antagonist pirenze- 
pine. The putative M 1 receptor exhibits high affin- 
ity for pirenzepine (K i < 30 nM), is stimulated by 
McN-A343, and is generally regarded to be cou- 
pled to PI turnover and Ca2+-mediated responses 
[41]. Conversely, the M 2 receptor should be rela- 
tively insensitive to pirenzepine inhibition or to 
stimulation by McN-A343, and should not stimu- 
late inositide turnover, but rather inhibit adeny- 
late cyclase [41]. In the dissociated salt gland cells, 
pirenzepine blocked both PI turnover and Ca 2+ 
responses, with K i values ranging from 90 to 227 
nM, while McN-A343 was ineffective as an agonist. 
Thus, this receptor appears to be of the M 2 sub- 
type based on the pharmacological classification, 
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but M 1 based on the fact that it stimulates in- 
ositide turnover. It may prove more meaningful to 
categorize the salt gland muscarinic acetylcholine 
receptor according to the classification described 
by Fisher et al. [42] for brain cholinergic receptors. 
The "group A" or full agonists are acetylcholine, 
carbachol, methacholine and muscarine, while 
"group B" or weak agonists include arecholine, 
pilocarpine and bethanechol as we have shown in 
salt gland cells (Table II). 
We have shown that while the mAChR-induced 
breakdown of cellular phosphoinositides is inde- 
pendent of extracellular Ca 2+, the change in 
[Ca2+]i requires external Ca 2+. The concentra- 
tion-response relationships for carbachol-induced 
inositol phosphate release, [Ca2+] i  signaling, and 
[32p]PI labeling suggest in addition to a causal 
relationship with mAChR activation, the absence 
of amplification steps between these responses. 
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